Simba Gill

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Redwood City, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Simba Gill
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Simba Gill

Form 4 holding Director

Foghorn Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
25,000
Estimated value
$119,750
Report date
17 Jun 2025
Price
$4.79
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & CEO, Director

Evelo Biosciences, Inc.

Security class
Common Stock
Shares / value
17,758
Estimated value
$5,860
Report date
08 Nov 2023
Price
$0.3300
Ownership
Direct
Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
92,000
Estimated value
Report date
03 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & CEO, Director

Evelo Biosciences, Inc.

Security class
Restricted Stock Units
Shares / value
15,236
Estimated value
Report date
07 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Simba Gill

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .